Celldex Therapeutics (CLDX) FCF Margin Growth (5y) (2015 - 2026)
Celldex Therapeutics (CLDX) FCF Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Celldex Therapeutics | 2.34 Bn | 2.34 Bn | -1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.55 Mn |
| Dec 31, 2025 | -5.38 Mn |
| Jun 30, 2025 | -98,713.00 |
| Mar 31, 2025 | -717,561.00 |
| Dec 31, 2024 | -157,628.00 |
| Sep 30, 2024 | 31,506.00 |
| Jun 30, 2024 | 40,103.00 |
| Mar 31, 2024 | -2.53 Mn |
| Dec 31, 2023 | 8,024.00 |
| Sep 30, 2023 | 27,303.00 |
| Jun 30, 2023 | -965,916.00 |
| Mar 31, 2023 | -231,968.00 |
| Dec 31, 2022 | -79,339.00 |
| Sep 30, 2022 | -810,344.00 |
| Jun 30, 2022 | -1.35 Mn |
| Mar 31, 2022 | -1.21 Mn |
| Dec 31, 2021 | -322,500.00 |
| Sep 30, 2021 | -974,445.00 |
| Jun 30, 2021 | 207,640.00 |
| Mar 31, 2021 | -2,285.00 |